Immunotherapy with immunocytokines and PD-1 blockade enhances the anticancer activity of small molecule-drug conjugates targeting carbonic anhydrase IX
J. Millul, C. Krudewig, A. Zana, S. Dakhel Plaza, E. Puca, A. Villa, D. Neri, S. Cazzamalli
This study shows that combining SMDCs targeting carbonic anhydrase IX with immunotherapy enhances anticancer activity in mouse models of renal cell carcinoma and colorectal cancer.
bioRxiv · Jun 3, 2020Cancer Biology